Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Operating Leases (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Operating Leases for 4 consecutive years, with $419000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 43.07% to $419000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $419000.0 through Dec 2025, down 43.07% year-over-year, with the annual reading at $419000.0 for FY2025, 43.07% down from the prior year.
  • Operating Leases for Q4 2025 was $419000.0 at Spruce Biosciences, down from $500000.0 in the prior quarter.
  • The five-year high for Operating Leases was $1.3 million in Q4 2022, with the low at $419000.0 in Q4 2025.
  • Average Operating Leases over 4 years is $909000.0, with a median of $974000.0 recorded in 2022.
  • The sharpest move saw Operating Leases grew 8.52% in 2023, then plummeted 43.07% in 2025.
  • Over 4 years, Operating Leases stood at $1.3 million in 2022, then decreased by 19.19% to $1.0 million in 2023, then dropped by 27.77% to $736000.0 in 2024, then tumbled by 43.07% to $419000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $419000.0, $500000.0, and $580000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.